Today AUG 5th, 2020 PCT LTD Provides Update on US Healthcare-related Activities
9:00 am ET August 5, 2020 (BusinessWire)
PCT LTD (OTC Pink: PCTL) is continuing its rapid expansion into the US Healthcare market with installations and targeted activities in multiple US Healthcare facilities nation-wide.
PCTL, owner of the patented Annihilyzer(R) Infection Control System is continuing its accelerated growth path with additional targeting and installation of systems in the US Healthcare market.
Following up on an earlier release, a system installation was performed for an existing hospital client in NYC through PCTL's primary healthcare distributor, ACE Janitorial Services. This installation was completed in mid-June, the last of three scheduled installations mentioned in an April 14th press release. The other two installations mentioned in the same announcement were completed and mentioned in a release on May 8th of this year.
Additional and ongoing activities in the US Healthcare market include, but are not limited to:
Installation of 5 additional systems with an existing NYC Hospital client. Pending final approval for an additional installation of two systems at a third, existing NYC Hospital client. In the quoting phase, an additional system order is pending approval for a large hospital network in upstate New York. In the quoting phase, an additional system order is pending approval for a large hospital network in Connecticut. In the quoting phase, an additional system order is pending approval for a large hospital network in Tennessee.
System orders which have reached the quoting phase, barring any unforeseen restrictions or difficulties, should receive final approval and be installed within 30-60 days. Existing healthcare clients awaiting final approval should see installations commence within 30-60 days.
"The quoting phase can be a necessarily lengthy process at times," explains Darryl Patterson, PCTL's Director of Healthcare. "At this stage, multiple parties within a hospital organization need to give their final approval before we can move forward. Once approved, we can schedule installations."
Over the last several months, the company had shifted their focus towards fluid production and distribution due to increased demand brought on by the ongoing COVID-19 pandemic, coupled with travel restrictions. The company's fluid production strength and sales remain strong and on pace for record growth in 2020. Healthcare facility installations are a central focus of the company's long-term growth plan.
"The pandemic had understandably caused disruption to on site outreach as well as installations," says PCTL CEO Gary Grieco. "With more states relaxing travel restrictions, we can continue moving forward at a healthy pace. Interest is as high as ever and we could not be happier to have the opportunity to continue our healthcare expansion efforts. We expect to continue to market and install systems in the United States at a steady pace through the end of the year."
Through the company's primary healthcare distributor, ACE Janitorial Services, PCTL now has 18 hospitals in the US which are using the company's bottled Hydrolyte(R) solution or utilizing on-site equipment, primarily PCTL's Annihilyzer(R) Infection Control System.
In addition, the company's large network of distributors and sub-registrants may also count hospital and healthcare facilities among their clientele in different geographical regions. PCTL will be providing additional updates regarding its growing network of distributors and sub-registrants in a release in the near future.
ADDITIONAL NEWS AND CORPORATE UPDATES:
PCTL would like to warn its stockholders and potential investors that material corporate information regarding sales, areas of business and other corporate updates will only be made through press releases or filings with the SEC. PCTL does not utilize social media, chatrooms or other online sources to disclose material information. The public should only rely on official press releases and corporate filings for accurate and up to date information regarding PCTL.
About PCT LTD:
PCT LTD ("PCTL"
focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC, "PCTL" aspires to and is actively engaged in preparations for up-listing its common stock to a national securities exchange. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K.
Forward-Looking Statements:
This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements."
Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: the ability of PCTL's most recently added distributors to gain and maintain certain saturation levels within their regions and/or markets; PCTL's continued installation of equipment; subsequent installations of PCT's Annihilyzer Infection Control Systems and the order/fulfillment process associated; PCTL's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCTL to execute its business plan; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCTL makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the SEC. PCTL undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200805005571/en/
SOURCE: PCT LTD">
Gary Grieco, CEO and Chairman, PCT LTD
(843) 390-7900 Office
(843) 390-2347 Fax
www.para-con.com
www.pctcorphealth.com
www.survivalyte.com
Rich Inza, Investor Relations (RMJ Consulting, LLC)
(843) 491-4611
IR@para-con.com
9:00 am ET August 5, 2020 (BusinessWire)
PCT LTD (OTC Pink: PCTL) is continuing its rapid expansion into the US Healthcare market with installations and targeted activities in multiple US Healthcare facilities nation-wide.
PCTL, owner of the patented Annihilyzer(R) Infection Control System is continuing its accelerated growth path with additional targeting and installation of systems in the US Healthcare market.
Following up on an earlier release, a system installation was performed for an existing hospital client in NYC through PCTL's primary healthcare distributor, ACE Janitorial Services. This installation was completed in mid-June, the last of three scheduled installations mentioned in an April 14th press release. The other two installations mentioned in the same announcement were completed and mentioned in a release on May 8th of this year.
Additional and ongoing activities in the US Healthcare market include, but are not limited to:
Installation of 5 additional systems with an existing NYC Hospital client. Pending final approval for an additional installation of two systems at a third, existing NYC Hospital client. In the quoting phase, an additional system order is pending approval for a large hospital network in upstate New York. In the quoting phase, an additional system order is pending approval for a large hospital network in Connecticut. In the quoting phase, an additional system order is pending approval for a large hospital network in Tennessee.
System orders which have reached the quoting phase, barring any unforeseen restrictions or difficulties, should receive final approval and be installed within 30-60 days. Existing healthcare clients awaiting final approval should see installations commence within 30-60 days.
"The quoting phase can be a necessarily lengthy process at times," explains Darryl Patterson, PCTL's Director of Healthcare. "At this stage, multiple parties within a hospital organization need to give their final approval before we can move forward. Once approved, we can schedule installations."
Over the last several months, the company had shifted their focus towards fluid production and distribution due to increased demand brought on by the ongoing COVID-19 pandemic, coupled with travel restrictions. The company's fluid production strength and sales remain strong and on pace for record growth in 2020. Healthcare facility installations are a central focus of the company's long-term growth plan.
"The pandemic had understandably caused disruption to on site outreach as well as installations," says PCTL CEO Gary Grieco. "With more states relaxing travel restrictions, we can continue moving forward at a healthy pace. Interest is as high as ever and we could not be happier to have the opportunity to continue our healthcare expansion efforts. We expect to continue to market and install systems in the United States at a steady pace through the end of the year."
Through the company's primary healthcare distributor, ACE Janitorial Services, PCTL now has 18 hospitals in the US which are using the company's bottled Hydrolyte(R) solution or utilizing on-site equipment, primarily PCTL's Annihilyzer(R) Infection Control System.
In addition, the company's large network of distributors and sub-registrants may also count hospital and healthcare facilities among their clientele in different geographical regions. PCTL will be providing additional updates regarding its growing network of distributors and sub-registrants in a release in the near future.
ADDITIONAL NEWS AND CORPORATE UPDATES:
PCTL would like to warn its stockholders and potential investors that material corporate information regarding sales, areas of business and other corporate updates will only be made through press releases or filings with the SEC. PCTL does not utilize social media, chatrooms or other online sources to disclose material information. The public should only rely on official press releases and corporate filings for accurate and up to date information regarding PCTL.
About PCT LTD:
PCT LTD ("PCTL"
focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC, "PCTL" aspires to and is actively engaged in preparations for up-listing its common stock to a national securities exchange. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K. Forward-Looking Statements:
This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements."
Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: the ability of PCTL's most recently added distributors to gain and maintain certain saturation levels within their regions and/or markets; PCTL's continued installation of equipment; subsequent installations of PCT's Annihilyzer Infection Control Systems and the order/fulfillment process associated; PCTL's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCTL to execute its business plan; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCTL makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the SEC. PCTL undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200805005571/en/
SOURCE: PCT LTD">
Gary Grieco, CEO and Chairman, PCT LTD
(843) 390-7900 Office
(843) 390-2347 Fax
www.para-con.com
www.pctcorphealth.com
www.survivalyte.com
Rich Inza, Investor Relations (RMJ Consulting, LLC)
(843) 491-4611
IR@para-con.com
